Meg Knowling
Impact in
- Cancer Research top 2%
- Breast Cancer Treatment Studies
-
- Breast Lesions and Carcinomas
Papers in
-
- Head and Neck Cancer Studies 2
-
- Gastrointestinal Tumor Research and Treatment 2
- Co-authors
- R. E. DurandStewart M. JacksonMohamed ManjiL. WeirKenneth S. WilsonNhu LeA. J. ColdmanJoseph Ragaz
- Journals
- Annals of Oncology (4 papers)JNCI Journal of the National Cancer Institute (2 papers)Journal of Clinical Oncology (2 papers)Investigational New Drugs (1 paper)Breast Cancer Research and Treatment (1 paper)
- Partner nations
- CanadaUnited StatesUnited Kingdom
In The Last Decade
Meg Knowling
13 papers receiving 954 citations
Hit Papers
Peers
Comparison fields: 5 of 65
- Cancer Research 659
- Pathology and Forensic Medicine 383
- Radiation 136
- Oncology 353
- Otorhinolaryngology 33
Countries citing papers authored by Meg Knowling
This map shows the geographic impact of Meg Knowling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meg Knowling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meg Knowling more than expected).
Fields of papers citing papers by Meg Knowling
This network shows the impact of papers produced by Meg Knowling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meg Knowling. The network helps show where Meg Knowling may publish in the future.
Co-authors
The 25 scholars most cited alongside Meg Knowling, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 41 | |
| 2 | 2009 | 29 | |
| 3 | 2008 | 12 | |
| 4 | 2007 | 5 | |
| 5 | 2006 | 69 | |
| 6 | Locoregional Radiation Therapy in Patients With High-Risk Breast Cancer Receiving Adjuvant Chemotherapy: 20-Year Results of the British Columbia Randomized Trial Hit paper breakdown → | 2005 | 757 |
| 7 | 2005 | 7 | |
| 8 | 2001 | 3 | |
| 9 | 1995 | 28 | |
| 10 | 1992 | 2 | |
| 11 | 1989 | 32 | |
| 12 | Perioperative chemotherapy for primary sarcoma of bone. | 1989 | 4 |
| 13 | Phase II study of mitoxantrone in untreated and previously minimally treated patients with metastatic soft tissue sarcomas. | 1987 | 7 |
About Meg Knowling
Meg Knowling is a scholar working on Otorhinolaryngology, Gastroenterology, Pulmonary and Respiratory Medicine, Oncology and Cancer Research, having authored 13 papers that have together received 996 indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (6 papers), Vascular Tumors and Angiosarcomas (2 papers), Breast Cancer Treatment Studies (2 papers), Histone Deacetylase Inhibitors Research (2 papers), Head and Neck Cancer Studies (2 papers), Gastrointestinal Tumor Research and Treatment (2 papers), Protein Degradation and Inhibitors (2 papers) and Cancer therapeutics and mechanisms (1 paper). The work is most often cited by research in Cancer Research (659 citations), Pathology and Forensic Medicine (383 citations), Radiation (136 citations), Oncology (353 citations) and Otorhinolaryngology (33 citations). Meg Knowling has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include R. E. Durand, Stewart M. Jackson, Mohamed Manji, L. Weir, Kenneth S. Wilson, Nhu Le, A. J. Coldman, Joseph Ragaz, Natasha Phillips and Ivo A. Olivotto. Their work appears in journals such as Annals of Oncology, JNCI Journal of the National Cancer Institute, Journal of Clinical Oncology, Investigational New Drugs and Breast Cancer Research and Treatment.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.